University of Vermont

The University of Vermont Cancer Center

Bio for Mark Evans, Ph.D.
Mark Evans, Ph.D.

Mark Evans, Ph.D.

Assistant Professor, Department of Pathology & Laboratory Medicine
Technical Director, Biobank, UVM Cancer Center, Department of Pathology & Laboratory Medicine

Contact Information
Office Location:
Given Building, C226, 89 Beaumont Ave., Burlington, VT 05405

Research Interests

Developing and optimizing immunohistochemical and in situ hybridization assays, and particular interest in human papillomaviruses (HPV), breast and cervical disease.

Postdoctoral Training

Jan.-June 2000 Post-Doctoral Research Associate, Department of Pathology, University of Vermont, Burlington, VT, USA
1996-1999 Post-Doctoral Research Assistant, Department of Pathology, Royal Liverpool University Hospital, Liverpool, UK


1991-1996 Ph.D. University of Hertfordshire in collaboration with University of Oxford Nuffield Department of Pathology, UK
1978 -1982 University of Surrey, Guildford, Surrey, UK Honors Degree: Human Biology

Academic Appointments

2014-present Research Assistant Professor, Technical Director of the UVMCC Biobank, Department of Pathology & Laboratory Medicine, University of Vermont
2004 – 2014 Research Assistant Professor, Scientific Director of the Experimental Pathology Laboratory, Department of Pathology, University of Vermont
2000 – 2004 Research Assistant Professor, Department of Pathology, University of Vermont


Zhang Z, Weaver DL, Olsen D, deKay J, Peng Z, Ashikaga T, Evans MF. Long non-coding RNA chromogenic in situ hybridization signal pattern correlation with breast tumor pathology. J Clin Pathol. 2015; epub ahead of print (PMID: 26323944)

Bumrungthai S, Munjal K, Nandekar S, Cooper K, Ekalaksananan T, Pientong C, Evans MF. Epidermal growth factor receptor pathway mutation and expression profiles in cervical squamous cell carcinoma: therapeutic implications. J Transl Med. 2015;13:244. (PMID: 26209091)

Ades S, Kumar S, Alam M, Goodwin A, Weckstein D, Dugan M, Ashikaga T, Evans MF, Verschraegen C, Holmes CE. Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer. J Thromb Haemost. 2015;13:998-1003. doi: 10.1111/jth.12910. (PMID: 25809746)

Bumrungthai S, Ekalaksananan T, Evans MF, Chopjitt P, Tangsiriwatthana T, Patarapadungkit N, Kleebkaow P, Luanratanakorn S, Kongyingyoes B, Worawichawong S, Pientong C. Up-Regulation of miR-21 Is Associated with Cervicitis and Human Papillomavirus Infection in Cervical Tissues. PLoS One. 2015;10(5):e0127109. (PMID: 26010154)

Zhang Z, Weaver DL, Munjal K, Evans MF. Intratumoral DNA content heterogeneity in breast carcinomas demonstrated by core punch tissue sampling and flow cytometry. J Clin Pathol. 2014;67:817-20. (PMID: 24942799)

To view all of Mark Evan's publications, please visit PubMed.